52087-58-8 ((Prosta-5,10,13-trien-1-oicacid, 15,19-dihydroxy-9-oxo-, (5Z,13E,15S,19R)- (9CI))

Prosta-5,10,13-trien-1-oicacid, 15,19-dihydroxy-9-oxo-, (5Z,13E,15S,19R)- (9CI);19(R)-hydroxy Prostaglandin A2;7-[(1R,2S)-2-[(3S,7R)-3,7-dihydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid;CTK1G9235;LMFA03010166;SR-01000946833;19(R)-hydroxy-Prostaglandin A2;CHEBI:165310;SR-01000946833-1;9-oxo-15S,19R-dihydroxy-5Z,10Z,13E-prostatrienoic acid;(Z)-7-[(1R,2S)-2-[(E,3S,7R)-3,7-dihydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid;PD021380;19R-hydroxy-PGA2;SCHEMBL14577814;Prosta-5,10,13-trien-1-oicacid,15,19-dihydroxy-9-oxo-,(5Z,13E,15S,19R)-(9ci);Prosta-5,10,13-trien-1-oic acid, 15,19-dihydroxy-9-oxo-,(5Z,13E,15S,19R)-;52087-58-8;19(R)-HYDROXYPROSTAGLANDINA2;(5Z,13e,15s,19r)-15,19-dihydroxy-9-oxo-prosta-5,10,13-trien-1-oic acid;DB-215008;19(R)-hydroxy PGA2;

RXYQCXVUMLSFHM-HCLDBPGNSA-N

1S/C20H30O5/c1-15(21)7-6-8-17(22)13-11-16-12-14-19(23)18(16)9-4-2-3-5-10-20(24)25/h2,4,11-18,21-22H,3,5-10H2,1H3,(H,24,25)/b4-2-,13-11+/t15-,16+,17+,18-/m1/s1

O=C1C=C[C@H](/C=C/[C@H](CCC[C@@H](C)O)O)[C@H]1C/C=C\CCCC(=O)O